University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...

Recently, scientists have been able to explore gene circuitry in individual cells using methods that suppress particular ...

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 2.9% on Thursday after an insider sold shares in the company. The company traded as low as $42.78 and last traded at $42.22. 282,558 shares ...

CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...

Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and ...

CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have been assigned a consensus recommendation of “Hold” from ...

The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...

Learn more about how a research team has successfully used CRISPR gene editing in the fight against cancer.

Head and neck cancers rank fifth in cancer-related mortality and often begin in the tongue, throat, or neck before metastasizing.

A new review in Engineering reveals that CRISPR technologies are revolutionizing regenerative medicine. Scientists from ...